Comprehensive Pediatrics Notes Summary & Study Notes

🧬 Growth and Development

Key concepts in pediatric growth include the measurement of weight, length/height, head circumference, and growth velocity across infancy and childhood. Growth is influenced by genetic, environmental, social, endocrine, nutritional, and cultural factors. Anthropometric measurements are used to monitor health and detect malnutrition or disease.

• Weight changes in the newborn period: newborns may lose up to $10$ of birth weight in the first week; term infants regain birth weight by $7$–$10$ days, while preterm infants regain by $10$–$14$ days. Weight gain rates vary with age.
• Infant weight gain: about $25$–$30$ g/day from $10$ days to $3$ months, reducing to around $12$ g/day by $10$–$12$ months.
• Milestones in weight: most infants double birth weight by $5$–$6$ months, triple by $12$ months, quadruple by age $2$ years, and about fivefold by age $3$ years.
• Measurements and tools: length is measured with an infantometer until age $2$, then standing height with a stadiometer; head circumference is measured with a non‑stretchable tape. Chest circumference and mid‑arm circumference (MAC) help assess brain growth and nutritional status, respectively. Skinfold thickness is used to assess adiposity, mainly at the triceps.
• Dentition and bone age: eruption sequences (primary then permanent teeth) and delayed eruption criteria (no teeth by $13$ months). Bone age assessment (e.g., Tanner–Whitehouse) and growth charts help monitor maturation.
• Growth velocity & short stature: velocity is the rate of height increase; maximum growth is in the first year. Short stature is defined as height below the 3rd centile or >2 SD below the median; etiologies are physiological (constitutional delay, familial short stature) or pathological. A systematic assessment includes accurate height, body proportions, velocity, and comparison to population norms and genetic potential.
• Investigations & management: basic investigations (CBC, bone age, etc.) are used to evaluate short stature; management targets the underlying cause with nutrition optimization and psychological support when needed.

Summary of Part 3/51 (Growth and Development in Children)

• Constitutional Stunting: diagnosed by exclusion; monitored until puberty with no specific treatment.
• Familial Short Stature: genetics set low target height; growth velocity remains normal, and there are no abnormal physical findings.
• Constitutional Growth Delay: normal early growth with subsequent deceleration; delayed puberty and bone age; managed by observation.
• Psychosocial Dwarfism: due to emotional deprivation; supportive environment yields catch‑up growth after parental counseling.
• Tall Stature: usually normal variant but may reflect endocrine disorders.
• Failure to Thrive (FTT): inadequate caloric intake; etiologies include organic and non‑organic causes; treatment focuses on addressing underlying causes and improving nutrition.
• Obesity: defined by BMI and percentiles; multifactorial etiologies; management includes lifestyle modification and, in severe cases, pharmacologic or surgical options.
• Microcephaly / Macrocephaly: head circumference extremes with various etiologies.
• Development & Milestones: milestones across gross motor, language, social, and adaptive domains from birth to five years; screening tests and early assessment improve outcomes.
• Adolescence: rapid physical and psychosocial changes; defined by stages and influenced by environment and socioeconomic factors.

🧭 Developmental Milestones & Screening

Developmental milestones provide structured expectations for motor, language, social, and cognitive skills at key ages. Early identification of delays allows timely intervention and better outcomes. Common screening tools include standardized questionnaires and tests like the Denver Developmental Screening Test.

Developmental assessment involves evaluating multiple domains and using developmental quotients to identify delays. Clinicians combine history, observation, and age‑normed testing to guide referrals and therapies.

Adolescence (10–19 years) marks a period of rapid change; key milestones in puberty, psychosocial development, and risk behavior emerge during early, middle, and late phases. Socioeconomic and environmental factors shape health trajectories during this stage.

Bold terms: growth velocity, percentiles, Z‑scores, bone age, developmental delay, screening tools, Denver test, developmental quotient, pubertal stages (Tanner stages).

🥗 Nutrition & Protein‑Energy Malnutrition (PEM)

Nutrition in early childhood underpins growth, immune function, and neurodevelopment. PEM is a clinical syndrome caused by inadequate intake of protein, energy, vitamins, and other nutrients. Social determinants such as poverty, sanitation, and feeding practices strongly influence risk.

• Assessment of PEM: dietary history, clinical signs, biochemical tests, radiology, and most importantly anthropometry (weight‑for‑age, height‑for‑age, MUAC) to classify malnutrition severity.
• Classification of PEM: Wellcome Trust and IAP classifications use weight‑for‑age and edema to categorize PEM; Severe Acute Malnutrition (SAM) is defined by specific weight‑for‑height and edema criteria.
• Clinical features: hair and skin changes, irritability, growth retardation, and developmental delays.
• Management: stabilization (treatment of hypoglycemia, hypothermia, dehydration, infections) followed by rehabilitation and nutrition with Ready‑to‑Use Therapeutic Food (RUTF) for SAM if outpatient management is possible. Refeeding must be monitored to avoid refeeding syndrome.
• Vitamin A deficiency: pathophysiology and role in vision, immunity, and epithelial integrity; preventive strategies include nutrition and supplementation when deficient.

Key terms: Kwashiorkor (edematous malnutrition) vs Marasmus (non‑edematous malnutrition); RUTF; refeeding syndrome; MUAC; edema criteria.

🧪 Vitamins, Minerals & Micronutrients

Pediatric micronutrient deficiencies have wide clinical consequences. Vitamins A, D, E, K and B‑complex vitamins, plus trace elements like copper and zinc, play vital roles in vision, bone metabolism, hematopoiesis, immunity, and neurologic function.

• Vitamin A deficiency: major cause of preventable blindness; stages range from corneal xerosis to keratomalacia; treatment involves dosing strategies and prevention via diet and supplementation.
• Vitamin D deficiency (Rickets): leads to skeletal deformities; treat with vitamin D supplementation and sunlight exposure; monitor serum calcium and phosphate.
• Vitamin E deficiency: rare; neurologic symptoms and hemolytic anemia in malabsorption; high‑dose tocopherol may be indicated.
• Vitamin K deficiency: bleeding risk, especially in newborns; prophylaxis at birth is standard (intramuscular preferred for absorption).
• Thiamine (B1) deficiency: beriberi; supplementation essential in at‑risk populations.
• Riboflavin (B2), Niacin (B3), B6, B12, C (ascorbic acid): various presentations from dermatitis and cheilosis to anemia and bleeding disorders; management involves targeted supplementation.
• Trace elements: copper and zinc deficiencies affect growth, immunity, and neurologic function; dietary modification and supplementation are key.

Bold terms: Kwashiorkor, SAM, RUTF, refeeding syndrome, xerosis, keratomalacia, cheilosis, seborrheic rash, acrodermatitis enteropathica (as contextually implied).

🧬 Prenatal Diagnostics & Fetal Well‑Being

Prenatal diagnostic procedures enable fetal genetic assessment and risk stratification. Major techniques include chorionic villus sampling (CVS), amniocentesis, percutaneous umbilical blood sampling (PUBS), and preimplantation genetic diagnosis (PGD).

• Amniocentesis: ultrasound‑guided removal of amniotic fluid; performed in early ($10$–$14$ weeks) and second trimester ($16$–$20$ weeks); risks include miscarriage and clubfoot; analysis for AFP and acetylcholinesterase helps detect neural tube defects.

• PUBS: fetal blood sample obtained via umbilical cord; offers cytogenetic/DNA studies; gained use in fetal treatment in select cases; miscarriage risk $\sim$1–2% and preterm delivery risk ~5%.

• PGD: genetic analysis of embryos during IVF to select unaffected embryos.

• Fetal growth & macrosomia: FGR is defined as fetal measurements below the 10th percentile; macrosomia defined as birth weight >$4000$ g; causes include placental insufficiency and maternal conditions; Doppler ultrasonography and BPP help assess wellbeing.

• Fetal well‑being tests: NST, CST, BPP, and Doppler studies assess fetal oxygenation and perfusion.

• Intrapartum assessment: continuous fetal heart rate monitoring and interpretation of baseline rate, variability, and decelerations.

• Neonatal resuscitation & perinatal management: guidelines emphasize preparation, initial steps, and evaluation; resuscitation requires proper airway management and circulation support.

Vocab & concepts: FGR, macrosomia, BPP (biophysical profile), NST (nonstress test), CST (contraction stress test), Doppler indices, in utero therapy.

🍼 Neonatal Resuscitation, Birth Injuries & Newborn Care

Newborn care covers resuscitation, common birth injuries, infants of diabetic mothers, thermoregulation, and breastfeeding support.

1. Resuscitation guidelines: suction pressure not exceeding $100$ mmHg; compression:ventilation ratio $3:1$ (about $120$ events/min); delayed cord clamping for $30$–$60$ seconds in non‑resuscitated infants. For preterms (<$32$ weeks), wrap in plastic; adrenaline (epinephrine) dosing via IV $0.01$–$0.03$ mg/kg or ET $0.05$–$0.1$ mg/kg. Naloxone is not recommended for respiratory depression in newborns.
2. Withholding resuscitation: criteria include no heart rate recovery after 10 minutes or extreme prematurity (gestational age < $22$ weeks or 22–24 weeks after discussion); lethal congenital anomalies.
3. APGAR score: assessed at $1$ and $5$ minutes; if < $7$ at 5 minutes, reassess every $5$ minutes up to 20 minutes.
4. Birth injuries: cephalohematoma, caput succedaneum, subaponeurotic hemorrhage, Erb’s and Klumpke’s palsy, clavicle fracture.
5. Infants of diabetic mothers: maternal hyperglycemia → fetal hyperglycemia and hyperinsulinemia; risks include macrosomia and congenital malformations.
6. Hypothermia & KMC: keep warm via skin‑to‑skin contact (Kangaroo Mother Care) for stable LBW infants; monitor temperature and support feeding.
7. Neonatal jaundice & VKDB: distinguish physiological vs pathological jaundice; VKDB prophylaxis (vitamin K) reduces bleeding risk; monitor bilirubin levels and treat with phototherapy or exchange transfusion if needed.
8. Jaundice management: phototherapy is primary for hyperbilirubinemia; DVET (double volume exchange transfusion) for severe cases.

Neonatal Sepsis & RDS: early onset sepsis vs late onset; treat promptly; RDS due to surfactant deficiency; manage with CPAP and possibly surfactant therapy; TTNB is common in term infants after cesarean section and is usually self‑limited.

Bold terms: APGAR, BPP, KMC, VKDB, DVET, RDS, TTNB.

🩺 Hyperbilirubinemia, VKDB, Sepsis, RDS & TTNB — Partially overlapping Neonatal Topics

• Hyperbilirubinemia risk factors include primiparity, jaundice within 24 hours, gestational age < $35$–$36$ weeks, sibling history of treatment‑relevant jaundice, ABO/Rh incompatibility, high prevalence G6PD area, and excessive weight loss after discharge ($>3$ per day or $>7$ cumulatively).
• Diagnostic approach includes bilirubin quantification, Coombs tests, CBC, and urine analysis; phototherapy is the first line for many cases, with exchange transfusion for severe hyperbilirubinemia.
• VKDB occurs in breastfed infants without vitamin K prophylaxis; onset categories: early (within 24 hours), classical (1–7 days), and late (>7 days). Prophylaxis (IM or oral vitamin K) is standard; IM is often preferred.
• Neonatal sepsis presents as early or late onset with nonspecific symptoms; management includes blood cultures, septic screens, and antibiotics while providing supportive care.
• RDS is common in preterms due to surfactant deficiency; management includes CPAP, surfactant replacement, oxygen therapy, and monitoring for complications like pneumothorax or bronchopulmonary dysplasia.
• TTNB occurs in term infants, especially after elective cesarean delivery; generally self‑limited within 24–72 hours.

🧬 Inheritance Patterns & Genetic Counseling

Understanding inheritance helps with diagnosis, management, and family planning.

• Autosomal Recessive: affected when both copies are mutated; risk to offspring from carrier parents is $25$ affected, $50$ carrier, $25$ normal. Common examples: cystic fibrosis, phenylketonuria, sickle cell disease.
• X‑Linked Recessive: primarily affects males; carrier females have a $25$ chance of affected sons; affected fathers pass to all daughters as carriers. Examples: hemophilia, Duchenne muscular dystrophy.
• X‑Linked Dominant: often more severe in males; affected males pass to daughters only. Examples include Rett syndrome and vitamin D‑resistant rickets.
• Multifactorial/Polygenic: driven by multiple genes and environmental factors (e.g., neural tube defects, diabetes mellitus).
• Mitochondrial Disorders: maternally inherited; expression varies due to heteroplasmy (e.g., Leigh disease).
• Genomic Imprinting & Uniparental Disomy: parental origin affects expression; examples include Prader‑Willi, Angelman; Beckwith‑Wiedemann can involve imprinting errors or UPD.
• Common Chromosomal Disorders: Down syndrome (Trisomy 21) is most common; Edward (Trisomy 18) and Patau (Trisomy 13) have high mortality; sex chromosome disorders include Klinefelter ($47,XXY$) and Turner ($45,X$).
• Genetic Counseling: risk assessment, testing options, and psychosocial support for families.

Bold terms: imprinting, UPD, heteroplasmy, phenylketonuria, cystic fibrosis, Rett syndrome, Trisomy conditions.

🧬 Inborn Errors of Metabolism (IEMs) & Glycogen Storage Disorders

IEMs present in neonatal or later life with hypoglycemia, metabolic acidosis, or characteristic features.

• Age of onset: neonatal presentations (e.g., galactosemia, organic acidemias) or after introduction of foods (e.g., fructose metabolism disorders).
• Exam findings: doll facies in GSD, cataracts in galactosemia, sour urine odors in MSUD, etc.
• Investigations during hypoglycemia: plasma glucose, free fatty acids, ketones, lactate, ammonia; urine reducing substances point to galactosemia.
• Common disorders and features:
  • PKU: phenylalanine hydroxylase deficiency; high phenylalanine; restrict phenylalanine in diet.
  • Tyrosinemia: elevated tyrosine and methionine; dietary restrictions; nitisinone therapy.
  • Albinism: tyrosinase deficiency; manage with UV protection and genetics.
  • Homocystinuria: homocysteine elevations; hypermethylation and thrombotic risk; manage with diet and vitamins.
  • Maple Syrup Urine Disease (MSUD): branched-chain amino acid metabolism defect; neurotoxicity; dietary restriction and liver transplant in severe cases.
  • Galactosemia: galactose‑1‑phosphate uridyltransferase deficiency; lactose‑free diet is essential.
  • Hereditary Fructose Intolerance: fructose intolerance; eliminate fructose and sucrose from diet.
• Glycogen Storage Disorders (GSD): hypoglycemia with hepatomegaly; Type 1 (Von Gierke) involves glucose‑6‑phosphatase deficiency; doll facies; management centers on maintaining normoglycemia with starch or continuous feeds; liver transplantation is a consideration in some cases. Other types require tailored feeding regimens.
• Mucopolysaccharidoses (MPS): lysosomal storage disorders with progressive features; enzyme replacement therapy and supportive care are mainstays; skeletal and organ involvement are typical.
• Gaucher disease & Abetalipoproteinemia & A1AT deficiency & Wilson disease: diverse metabolic disorders with liver, hematologic, neurologic, and systemic manifestations; management includes enzyme replacement (where available), dietary modifications, and chelation or other disease‑specific therapies.

Bold terms: galactosemia, PKU, MSUD, GSD Type 1, Von Gierke, MPS, Gaucher, abetalipoproteinemia, Wilson disease.

🧠 Immunology & Immunodeficiencies

Pediatric immunology covers congenital and acquired immune defects, infection risk, and management strategies such as immunoglobulin replacement and HSCT.

• Adaptive immunity defects: B‑cell disorders (e.g., X‑linked agammaglobulinemia), CVID, Hyper‑IgM syndrome, selective IgA deficiency. These present with recurrent sinopulmonary infections and poor antibody responses.
• Combined B and T cell defects: SCID is a critical, life‑threatening condition needing urgent HSCT; other examples include Ataxia‑telangiectasia and Wiskott–Aldrich syndrome.
• Chronic granulomatous disease (CGD) & MPO deficiency: CGD features defective NADPH oxidase with recurrent infections; MPO deficiency is often mild but can predispose to candidiasis.
• CHS (Chediak–Higashi syndrome): autosomal recessive; impaired neutrophil function; life‑threatening HLH risk; treated with HSCT.
• IVIG: used for selected humoral immunodeficiencies; dosing and adverse effects vary with condition.
• Allergic conditions: allergic rhinitis and systemic anaphylaxis require avoidance, meds, and emergency treatment.

Bold terms: HSCT, CGD, SCID, IVIG, CVID, Hyper‑IgM, Wiskott–Aldrich, CHS.

🤧 Allergic Reactions & Bronchial Asthma in Children

Allergic reactions can range from urticaria to anaphylaxis; bronchial asthma is a common chronic inflammatory airway disease in children.

• Allergic reactions: exposure to foods, insect toxins; management includes airway stabilization, rapid epinephrine for anaphylaxis, and identifying triggers.
• Bronchial asthma: episodic airway obstruction with cough, wheeze, chest tightness; diagnosed by history, examination, and spirometry; treatment includes education, environmental control, relievers (short‑acting beta‑agonists) and controllers (inhaled corticosteroids, leukotriene inhibitors);
  • Severity levels: intermittent, mild/moderate/severe persistent; treatment is tiered by severity.
  • Status asthmaticus requires urgent escalation of therapy.
• Exercise‑induced bronchoconstriction: spirometry before/after exercise; preventive beta‑agonists prior to exercise.

Bold terms: anaphylaxis, spirometry, inhaled corticosteroids, leukotriene inhibitors, status asthmaticus.

🦴 Inflammatory Arthritis & Vasculitis in Children

Pediatric inflammatory arthritis includes JIA subtypes, SLE, dermatomyositis, and pediatric vasculitis such as Kawasaki disease and Takayasu arteritis.

• Juvenile Idiopathic Arthritis (JIA): systemic arthritis, oligoarthritis, polyarthritis (RF‑), polyarthritis (RF+), psoriatic arthritis, enthesitis‑related, and undifferentiated; diagnosis is clinical with lab tests to exclude other causes. Systemic JIA may have fever, rash, hepatosplenomegaly, while oligoarthritis affects a few joints and may respond well to NSAIDs.
• Systemic Lupus Erythematosus (SLE): multisystem autoimmune disease; management includes trigger avoidance and NSAIDs or corticosteroids for organ involvement.
• Juvenile Dermatomyositis: inflammatory myopathy with characteristic skin findings and proximal muscle weakness; treated with steroids and immunosuppressants.
• Vasculitis: Kawasaki disease features persistent fever and mucocutaneous signs and requires prompt treatment to prevent coronary complications; Takayasu arteritis is a large‑vessel vasculitis affecting young women; polyarteritis nodosa is a systemic necrotizing vasculitis.

Bold terms: JIA, SLE, Kawasaki disease, Takayasu arteritis, PAN, DM (dermatomyositis).

🧬 Infectious Diseases & Vaccinations in Pediatrics

Pediatric infectious diseases span bacterial, viral, and parasitic etiologies, with vaccination strategies to prevent common infections and reduce morbidity.

• HIV in children: vertical transmission risks and therapies; ART is essential; early diagnosis improves outcomes; breastfeeding transmission risks exist.

• Dengue & Malaria: transmitted via mosquitoes; clinical features range from fever to shock in dengue; malaria presents with fever, anemia, and splenomegaly; diagnosis via smear and RDTs; treatment varies by species and severity.

• Tuberculosis (TB): Mycobacterium tuberculosis; risk factors include malnutrition and HIV; diagnosis via microbiology and imaging; therapy involves intensive and continuation phases with adherence and monitoring.

• Vaccines: BCG, Hib, Pentavalent, MMR, Rotavirus, Rabies, Meningococcal, Cholera, Hepatitis B, Varicella, Typhoid, Hepatitis A, Pneumococcal vaccines; schedules and contraindications summarized; storage and cold chain important.

• Anemia in Pediatrics: common condition with global burden; WHO thresholds: < $11,g/dL$ for ages $6$ months–$5$ years and < $12,g/dL$ for ages $6$–$14$ years; etiologies include iron deficiency, vitamin deficiencies, thalassemia, blood loss, chronic disease; diagnosis relies on CBC, reticulocytes, smear, ferritin, and serum iron; management targets cause correction and nutritional support.

Bold terms: ART, BCG, Hib, MMR, RUTF, phototherapy, TB (tuberculosis), malaria, dengue, RSV (not listed but common), anemia thresholds, ferritin, reticulocyte count.

🧪 Tuberculosis, HIV, Dengue & Malaria — Diagnostics & Treatments

• HIV: vertical transmission, with risk reduction strategies including zidovudine prophylaxis and possible cesarean delivery in high viral loads; antiretroviral therapy (ART) tailored by age and disease status.

• Dengue & Malaria: prevention via vector control and vaccination when available; treatment is supportive with careful fluid management in dengue and antimalarial therapy in malaria.

• HIV diagnosis in children: DNA/RNA PCR before 18 months; after 18 months, serology testing is used.

• Vaccination overview: vaccines reduce incidence and complications of many diseases; immunization schedules vary by country and risk groups. Vaccines mentioned include BCG, Hib, Pentavalent, MMR, Rotavirus, Rabies, Meningococcal, Cholera, HepB, Varicella, Typhoid, HepA, and Pneumococcal.

🩸 Anemia in Pediatrics — Causes, Diagnosis & Management

Anemia is a reduction in hemoglobin concentration impairing oxygen transport. It is prevalent in preschool children, particularly in rural settings.

• WHO thresholds: anemia defined as Hb < $11.0,g/dL$ in children 6 months–5 years; Hb < $12.0,g/dL$ in children 6–14 years.
• Causes: involve inadequate dietary intake, poor absorption, increased demands, hemolysis, blood loss, and chronic disease.
• Classification: (i) Blood loss (acute or chronic), (ii) Impaired red cell production (iron deficiency, vitamin deficiencies, thalassemias), (iii) Increased destruction (hemolytic anemias).
• Clinical features: fatigue, pallor, growth retardation, and related symptoms.
• Investigations: CBC, reticulocyte count, peripheral smear, serum iron studies; further tests guided by suspected etiology.

Bold terms: Hb thresholds, iron deficiency, thalassemia, reticulocytes, ferritin, anemia due to malnutrition.